myStoria raises $1.625M seed round and expands reproductive health platform
Vision is to create a health partner for life
myStoria, a reproductive health platform combining artificial intelligence with human support, has raised $1.625 million in seed funding and announced an expansion of its product to cover the full reproductive health lifecycle.
The platform functions as a patient-facing care coordination tool, allowing users to build a longitudinal record of their health history - including symptoms, test results, appointments and personal notes - and use AI to then surface patterns, generate insights and prepare for clinical visits. This is paired with access to trained professionals who review and contextualise outputs, positioning myStoria as both a record system and a navigation layer across fragmented care pathways.
The round was led by Graphite Ventures, with participation from Conexus Venture Capital, Adrenaline Fund, Phoenix Fire Fund and a group of angel investors.
The company said the funding will support product development, expansion beyond fertility into broader reproductive health conditions, and the rollout of its mobile app with a freemium access model.
“Reproductive health has the highest dismissal rates, the longest diagnostic delays, and the most fragmented care of any condition,” said Jessica Chalk, founder and CEO of myStoria.
“This funding lets us extend across the full lifecycle.”
Expansion beyond fertility
myStoria is expanding its platform from a focus on fertility navigation to include a wider set of reproductive health needs, including painful periods, PCOS, endometriosis, perimenopause and hormonal health.
The platform is now available on iOS and Android, with free access to AI-powered guidance and health record organisation, and paid tiers starting at $19 per month for access to trained professionals.
myStoria is positioned as a tool to support patients managing their own care across fragmented healthcare systems. The platform combines AI with human review to help users organise medical records, track symptoms and prepare for appointments.
“Nobody has ever built for the patient, said Jessica. “Now we are. We are not fighting the system, we’re building the layer that was always missing from it.”
The company’s “context engine” aggregates data including documents, appointment history, symptoms and personal notes into a structured format designed for AI analysis. According to the company, trained professionals review AI-generated outputs to add clinical context.
The approach is intended to address what investors described as a structural gap in healthcare.
“What drew us to myStoria was their insight that complex healthcare is a burden failure, not just an information gap,” said Aaron Bast, general partner at Graphite Ventures.
Alex Shimla, principal at Conexus Venture Capital, added that patients are often left to coordinate care themselves across multiple providers and systems, with little formal support.
Product features and model
The expanded platform includes several core features: longitudinal health record tracking, AI-driven insights to identify patterns, appointment preparation tools, and condition-specific pathways. It also offers access to trained professionals who can provide guidance without requiring referrals or formal diagnoses.
The company said its model is designed to reduce the cognitive and administrative burden on patients, particularly in conditions where diagnosis can take years. It cited examples such as endometriosis, where diagnosis delays can span seven to ten years, and PCOS, which affects around one in ten people with ovaries but is often underdiagnosed.
“No provider has the full picture. Not because they don’t want it, but because the system was not built to give it to them,” said Jessica Chalk.
“When we help patients organize their story and show up prepared, the dynamic in the room shifts. The provider gets more. The patient gets more. The patient has always been the most important, most underutilized advocate in their own care. We set out to build what should have existed from the beginning.”
Long-term strategy
While myStoria is initially focused on reproductive health, the company said its longer-term ambition is to expand into other areas of complex care, including chronic and multi-condition management.
The underlying premise is that patients act as the central point across their healthcare journeys, but lack tools to manage that role effectively.
myStoria says that it sees reproductive health is the wedge but that the broader vision is to create a health partner for life.
The company, headquartered in Kitchener, Ontario, was founded by a team with lived experience of navigating reproductive healthcare and is positioning itself as a patient-centric infrastructure layer, rather than a provider- or employer-led solution.